PENGGUNAAN KATETER INTRAPLEURA (WATER SEALED DRAINAGE, INDWELLING PLEURAL CATHETER, PIGTAIL CATHETER) PADA PENATALAKSANAAN KANKER PARU DENGAN EFUSI PLEURA MASIF

  • Tamam Anugrah TAMSIL Universitas Islam Sumatera Utara
  • Elisna SYAHRUDDIN Universitas Indonesia
  • Dicky SOEHARDIMAN Universitas Indonesia
DOI: https://doi.org/10.36656/jpkm.v1i2.115
Keywords: Lung cancer, massive pleural effusion, intrapleural catheter

Abstract

Massive pleural effusion is one of the problems in lung cancer treatment that cause death. The main treatment of cancer patient with massive pleural effusion is the placement of intrapleural catheter. This is a preliminary study which is aimed to assess tolerancies and efficacies of intrapleural catheter (WSD, IPC or pigtail catheter) in lung cancer with massive pleural effusion. This study is a retroscpective observational cohort study. Subjects are lung cancer patients with massive pleural effusion and catheterized with intrapleural catheter (WSD, IPC or pigtail catheter). The datas were taken from medical record at RSUP Persahabatan and assessed for tolerancies (acute or late complication) and efficacies ((length of hospital admission after catheter placement, duration and the reason of retraction) of intrapleural catheter. Tolerancies and efficacies of intrapleural catheter (WSD, IPC or pigtail catheter) in lung cancer patients with massive pleural effusion are quite good and safe. Prospective cohort studies are needed in the future to determine which type of intrapleural catheter is better for the treatment of massive pleural effusion in lung cancer patients.

References

American Thoracic Society. 2000. Management of malignant pleural effusion. Am J Respir Crit Care Med.,162:1987-97. Mangunnegoro H. 1998. Masalah efusi pleura di Indonesia. J Respir Indo, 18:48-50. Syahruddin E, Pratama AD, Arief N. 2010. A retrospective study: clinical and diagnostic characteristics in advanced stage of lung cancer patients with pleural effussion in Persahabatan Hospital 2004–2007.J Respir Indo.; 30:146-50. Mahsal F, Syahruddin E, Soehardiman D. 2013. Angka tahan hidup penderita kanker paru berdasarkan kepositifan sitologi cairan pleura dan atau histopatologi biopsi pleura (Tesis). Fakultas Kedokteran Universitas Indonesia. Syahruddin E. 2013. The management of malignant pleural effusions. Perhimpunan Dokter Paru Indonesia. Konas PDPI Lampung. Lee G, Fysh ET, Waterer GW, Kendall PA, Bremner PR, Dina S, et al. 2012. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest.; 142(2):394-400. Gammie JS, Banks MC, Fuhrman CR, Pham SR, Griffith BP, Keenan RJ, et al. 1999. The pigtail catheter for pleural drainage : a less invasive alternative to tube thoracostomy. JSLS.; 3:57-61. Antunes G, Neville E, Duffy J, Ali N. 2003. BTS guidelines for the management of malignant pleural effusions. Thorax.; 58(suppl II): 29-38. Miserocchi G. 1997. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J.; 10:219-25. Porcel JM, Light RW. 2006. Diagnostic approach to pleural effusion in adults. Am Fam Physician.; 73:1211-20. Barus FA, Hudoyo A, Swidarmoko B. 2006. Perbandingan keberhasilan pleurodesis povidon iodin dengan doksisiklin pada efusi pleura ganas. J Respir Indo.; 26(2):69-85.
Van Meter ME, McKee KY, Kohlwes RJ. 2011. Efficacy and safety of tunneled pleural catheters in adult with malignant pleural effusions: a systematic review. J Gen Intern Med.; 26:70-6. Putnam JB, Light RW, Rodriguez RM. 1999. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer; 86:1992–9. Bediwy AS, Amer HG. 2012. Pigtail catheter use for draining pleural effusions of various etiologies. ISRN Pulmonology.; 8:77-83. Parulekar W, Di Primio G, Matzinger F, Dennie C. 2001. Use of small-bore vs large bore chest tubes for the treatment of malignant pleural effusions. Chest.; 120:19-25. Lui MM, Thomas R, Lee YCG. 2015. Complication of indwelling pleural catheter use and their management. BMJ.; 10:1-7. Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al. 2012. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion. JAMA.; 307:2383-9.
Trembley A, Michaud G. 2006. Single center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest.; 129(2):362-8. Bielsa S, Salud A, Martinez M, Esquerda A, Martin A, Rodriquez P, et al. 2008. Prognostic sifnificance of pleural fluid data in patients with malignant effusion. Eur J Int Med.; 19:334-9. Sallach SM, Sallach JA, Vasques E, Shultz I, Levak P. 2002. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest.; 122:1913-7. Park JO, Lee SI, Song SY, Kim K, Kim WS, Jung CW, et al. 2003. Measuring response in solid tumors : comparison of RECIST and WHO response criteria. Jpn J Clin Oncol.; 33:533-7. Fysh ET, Tremblay A, Feller-Kopman D, et al. 2013. Clinical outcome of indwelling pleural catheter-related pleural infections:an international multicenter study. Chest.; 144:1597-602. Castro DJ, Nuevo GN, Rodriquez EP. 1998. Cytologically proved malignant pleural effusion. Chest.; 1798-9.
Antony VB, Loddenkeper R, Astoul D, Boutin C, Golsstraw P, Holt J, et al. 2001. ERS/ATS statement: Management of malignant pleural effusin. Eur Respir J.; 18:402-19.
Published
2019-04-28
Issue
Vol 1 No 2 (2019): Jurnal Penelitian Keperawatan Medik
Section
Articles